Management of intracerebral hemorrhage
Management of intracerebral hemorrhage. Intracerebral hemorrhage represents a major public health problem because of its frequency and its high associated morbi-mortality. Thirty days post-hemorrhage, the mortality is evaluated at 42%. Intracerebral hemorrhage has the worst outcome of all types of stroke. In spite of 20 years of active research, the only treatment having proven its efficacy is hospitalization in a specialized unit. Clinicians will more likely to be confronted with intracerebral hemorrhage, because of the aging population and growing anticoagulation use. Each situation has its own specificities and deserves a specific aetiological work-up and care. We propose an up-to-date review of medical and surgical treatments that aim to reduce the size of heamtoma but also medical treatments that aim to reduce surrounding inflammation that contributes to the bad prognosis of intracerebral hemorrhage.